We are live on ! Find out more
ZJYL

Jin Medical International

17 hedge funds and large institutions have $747K invested in Jin Medical International in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

70% more funds holding

Funds holding: 10 → 17 (+7)

0.59% less ownership

Funds ownership: 1.23% → 0.64% (-0.59%)

50% less capital invested

Capital invested by funds: $1.5M → $747K (-$750K)

Holders
17
Holders Change
+7
Holders Change %
+70%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ZJYL Hedge Fund Activity: Q1 2025 in Review

17 of the 7,476 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q1 2025, worth a combined $747K — down 50% from $1.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ZJYL positions and 2 closed out — a net gain of 7 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $132K. The largest seller was Vanguard Group, exiting entirely with an estimated $1.13M sold.

  • 17 institutional investors held Jin Medical International (ZJYL) as of Q1 2025, up from 10 in Q4 2024.
  • Funds reported $747K of Jin Medical International stock for Q1 2025, down 50% quarter-over-quarter.
  • 9 funds opened new Jin Medical International positions in Q1 2025 and 2 closed out, a net change of +7 holders.
  • The largest Jin Medical International buyer in Q1 2025 was Jane Street, an estimated $132K added.
  • The largest Jin Medical International seller in Q1 2025 was Vanguard Group, an estimated $1.13M sold.

Based on aggregated 13F filings for Q1 2025.